Clinical trial
Role of Leptin in the Neuroendocrine and Immune Response to Fasting
NCT00140231 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00140231 |
|---|---|
| Title | Role of Leptin in the Neuroendocrine and Immune Response to Fasting |
| Official title | Role of Leptin in the Neuroendocrine and Immune Response to Fasting in Humans |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH National Center for Research Resources (NCRR) Amgen Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Fasting |
| Intervention type | Drug, Other |
| Interventions | r-metHuLeptin, placebo |
| Enrollment | 13 |
| Start date | Oct 1, 2002 |
| Primary completion | Mar 1, 2011 |
| Completion | Dec 1, 2016 |
| First posted | Sep 1, 2005 |
| Last update posted | Jun 7, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: